1. Home
  2. FEMY vs INHD Comparison

FEMY vs INHD Comparison

Compare FEMY & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • INHD
  • Stock Information
  • Founded
  • FEMY 2004
  • INHD 2019
  • Country
  • FEMY United States
  • INHD United States
  • Employees
  • FEMY N/A
  • INHD N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • INHD
  • Sector
  • FEMY Health Care
  • INHD
  • Exchange
  • FEMY Nasdaq
  • INHD Nasdaq
  • Market Cap
  • FEMY 18.6M
  • INHD 19.8M
  • IPO Year
  • FEMY 2021
  • INHD 2023
  • Fundamental
  • Price
  • FEMY $0.38
  • INHD $9.65
  • Analyst Decision
  • FEMY Strong Buy
  • INHD
  • Analyst Count
  • FEMY 3
  • INHD 0
  • Target Price
  • FEMY $7.33
  • INHD N/A
  • AVG Volume (30 Days)
  • FEMY 1.6M
  • INHD 16.3M
  • Earning Date
  • FEMY 08-08-2025
  • INHD 07-28-2025
  • Dividend Yield
  • FEMY N/A
  • INHD N/A
  • EPS Growth
  • FEMY N/A
  • INHD N/A
  • EPS
  • FEMY N/A
  • INHD N/A
  • Revenue
  • FEMY $1,887,016.00
  • INHD $2,645,845.00
  • Revenue This Year
  • FEMY $103.55
  • INHD N/A
  • Revenue Next Year
  • FEMY $148.13
  • INHD N/A
  • P/E Ratio
  • FEMY N/A
  • INHD N/A
  • Revenue Growth
  • FEMY 98.61
  • INHD 787.64
  • 52 Week Low
  • FEMY $0.31
  • INHD $1.11
  • 52 Week High
  • FEMY $1.80
  • INHD $19.78
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 24.33
  • INHD 86.44
  • Support Level
  • FEMY $0.36
  • INHD $4.71
  • Resistance Level
  • FEMY $0.42
  • INHD $6.09
  • Average True Range (ATR)
  • FEMY 0.06
  • INHD 1.65
  • MACD
  • FEMY -0.01
  • INHD 0.67
  • Stochastic Oscillator
  • FEMY 16.48
  • INHD 80.52

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: